RxDoctor Payments DataLook up a doctor →

Nicholas Willis, MD

Cardiovascular Disease · Pine Bluff, ARNPI 1629292883

Payments from drug & device makers

$14,649in general payments, 2019–2025

Across 520 payments — averaging $28.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Penumbra, Inc.$2K
  • Amgen$1K
  • Novartis$1K
  • Merck$559
  • Pfizer$548
  • plus $5K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)39$3,918
Penumbra, Inc.7$2,156
Amgen80$1,347
Novartis97$1,180
Merck28$559
Pfizer38$548
Johnson & Johnson30$509
Actelion Pharmaceuticals US, Inc.22$468
Abbott9$432
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)12$335
Abiomed5$252
Sanofi-aventis U.S. LLC16$242
AstraZeneca15$220
E.r. Squibb & Sons, L.L.C.12$192
GSK12$188
Novo Nordisk8$174
Edwards Lifesciences1$173
Philips North America LLC8$150
Shockwave Medical, Inc1$148
Esperion Therapeutics, Inc.10$139
Mallinckrodt Enterprises LLC7$131
Boston Scientific6$123
Lexicon Pharmaceuticals, Inc.7$123
Cardiovascular Systems Inc.10$108
Baxter Healthcare2$103
Scpharmaceuticals Inc.5$102
Regeneron Healthcare Solutions, Inc.6$86
Alnylam Pharmaceuticals Inc.4$77
Boehringer Ingelheim5$76
Irhythm Technologies, Inc.4$72
Mallinckrodt Hospital Products Inc.3$70
Cvrx, Inc.2$51
Bayer2$37
Coloplast1$32
Kestra Medical Technology Services, Inc.1$25
Elutia, Inc.1$23
Cardiva Medical, Inc.1$22
Genentech USA, Inc.1$20
Bridgebio Pharma, Inc.1$17
Sunovion Pharmaceuticals Inc.1$17

How this compares

$14,649 in reported general payments places this provider in the 75th percentile of 130 cardiovascular disease providers in Arkansas.

See all cardiovascular disease providers in Arkansas →

Medicare billing

Part B allowed, 2024
$439,243
Medicare patients
1,476
Services billed
6,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Pine Bluff

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →